SCHEMBL4049407

SCHEMBL4049407

COC(=O)c1ccccc1Cl.OBO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.55
TSHR P16473 2/20 0.55
KMT2A Q03164 4/20 0.54
ALDH1A1 P00352 3/20 0.54
MAPT P10636 2/20 0.54
CFTR P13569 1/20 0.53
HSD17B10 Q99714 1/20 0.53
SLC6A4 P31645 1/20 0.53
SLC6A3 Q01959 1/20 0.53
CES2 O00748 1/20 0.52
CES1 P23141 1/20 0.52
POLB P06746 2/20 0.52
KDM4E B2RXH2 1/20 0.52
ATM Q13315 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
MEN1 O00255 1/20 0.50
HPGD P15428 2/20 0.49
NR4A2 P43354 2/20 0.49
ERCC5 P28715 1/20 0.49
FEN1 P39748 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL196555 0.94 LMNA (0.61) LMNATSHRKMT2AALDH1A1MAPT
SCHEMBL30488606 0.94 LMNA (0.61) LMNATSHRKMT2AALDH1A1MAPT
Hydrochloric Acid SCHEMBL30910342 0.92 LMNA (0.59) LMNATSHRKMT2AALDH1A1MAPT
SCHEMBL28324413 0.92 LMNA (0.59) LMNATSHRKMT2AALDH1A1MAPT
SCHEMBL27542799 0.87 CA1 (0.54) LMNATSHRKMT2AALDH1A1MAPT
Cadaverine Tartrate SCHEMBL29131137 0.82 LMNA (0.52) LMNATSHRKMT2AALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL30676257 0.82 ALDH1A1 (0.49) LMNATSHRKMT2AALDH1A1MAPT
SCHEMBL31591207 0.79 SLC6A3 (0.65) LMNATSHRKMT2AALDH1A1MAPT
SCHEMBL28982652 0.79 LMNA (0.48) LMNATSHRKMT2AALDH1A1MAPT
Dimethyl Phthalate SCHEMBL790124 0.79 TSHR (0.74) LMNATSHRKMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2020404-A1 Cyanomethyl substituted N-Acyl Tryptamines Bayer Schering Pharma Aktiengesellschaft (DE) 2009-02-04 EP disclosed